Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SeaStar Medical Holding (ICU) Return on Sales (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Return on Sales for 3 consecutive years, with 18.97% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 4688.0% year-over-year to 18.97%, compared with a TTM value of 16.1% through Sep 2025, down 25087.0%, and an annual FY2024 reading of 183.93%, changed N/A over the prior year.
  • Return on Sales was 18.97% for Q3 2025 at SeaStar Medical Holding, down from 5.92% in the prior quarter.
  • Across five years, Return on Sales topped out at 167.72% in Q2 2024 and bottomed at 126.26% in Q4 2024.
  • Average Return on Sales over 3 years is 9.17%, with a median of 2.48% recorded in 2025.
  • Peak annual rise in Return on Sales hit 15684bps in 2024, while the deepest fall reached -17638bps in 2024.
  • Year by year, Return on Sales stood at 50.13% in 2023, then tumbled by -352bps to 126.26% in 2024, then skyrocketed by 85bps to 18.97% in 2025.
  • Business Quant data shows Return on Sales for ICU at 18.97% in Q3 2025, 5.92% in Q2 2025, and 12.87% in Q1 2025.